Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Self-Injurious Behavior
NCT02726035Phase 4Withdrawn
- Sponsor
- Western Michigan University Homer Stryker M.D. School of Medicine
- Start
- Feb 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in Self-injurious behavior, sponsored by Western Michigan University Homer Stryker M.D. School of Medicine. Planned start Feb 2014; status: withdrawn.
02
Drugs
naltrexone
03
Conditions
Self-injurious behavior
Beyond the preview
Go deeper on NCT02726035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726035.